[HTML][HTML] Active surveillance in intermediate-risk prostate cancer: a review of the current data
L Blas, M Shiota, M Eto - Cancers, 2022 - mdpi.com
Simple Summary AS is an option for the initial management of selected patients with
intermediate-risk PC. The proper way to predict which men will have an aggressive clinical …
intermediate-risk PC. The proper way to predict which men will have an aggressive clinical …
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
L Blas, M Shiota, M Eto - Cancers, 2022 - pubmed.ncbi.nlm.nih.gov
Active surveillance (AS) is a monitoring strategy to avoid or defer curative treatment,
minimizing the side effects of radiotherapy and prostatectomy without compromising …
minimizing the side effects of radiotherapy and prostatectomy without compromising …
[HTML][HTML] Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
L Blas, M Shiota, M Eto - Cancers, 2022 - ncbi.nlm.nih.gov
Active surveillance (AS) is a monitoring strategy to avoid or defer curative treatment,
minimizing the side effects of radiotherapy and prostatectomy without compromising …
minimizing the side effects of radiotherapy and prostatectomy without compromising …
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data.
L Blas, M Shiota, M Eto - Cancers, 2022 - europepmc.org
Active surveillance (AS) is a monitoring strategy to avoid or defer curative treatment,
minimizing the side effects of radiotherapy and prostatectomy without compromising …
minimizing the side effects of radiotherapy and prostatectomy without compromising …
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
L Blas, M Shiota, M Eto - Cancers, 2022 - kyushu-u.elsevierpure.com
Active surveillance (AS) is a monitoring strategy to avoid or defer curative treatment,
minimizing the side effects of radiotherapy and prostatectomy without compromising …
minimizing the side effects of radiotherapy and prostatectomy without compromising …
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data.
L Blas, M Shiota, M Eto - Cancers, 2022 - search.ebscohost.com
Simple Summary: AS is an option for the initial management of selected patients with
intermediate-risk PC. The proper way to predict which men will have an aggressive clinical …
intermediate-risk PC. The proper way to predict which men will have an aggressive clinical …
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
L Blas, M Shiota, M Eto - Cancers, 2022 - search.proquest.com
Active surveillance (AS) is a monitoring strategy to avoid or defer curative treatment,
minimizing the side effects of radiotherapy and prostatectomy without compromising …
minimizing the side effects of radiotherapy and prostatectomy without compromising …
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data.
L Blas, M Shiota, M Eto - Cancers, 2022 - europepmc.org
Active surveillance (AS) is a monitoring strategy to avoid or defer curative treatment,
minimizing the side effects of radiotherapy and prostatectomy without compromising …
minimizing the side effects of radiotherapy and prostatectomy without compromising …